EKF Diagnostics (LON:EKF – Get Free Report) released its quarterly earnings data on Tuesday. The company reported GBX 0.54 earnings per share for the quarter, Digital Look Earnings reports. EKF Diagnostics had a return on equity of 3.01% and a net margin of 4.12%.
EKF Diagnostics Trading Down 1.2%
EKF stock opened at GBX 25.70 on Tuesday. The company has a debt-to-equity ratio of 2.01, a current ratio of 4.16 and a quick ratio of 1.77. EKF Diagnostics has a 1-year low of GBX 22 and a 1-year high of GBX 31.70. The business has a 50 day simple moving average of GBX 25.44 and a two-hundred day simple moving average of GBX 25.51. The company has a market capitalization of £110.04 million, a price-to-earnings ratio of 54.68 and a beta of 0.50.
EKF Diagnostics Company Profile
? Point-of-Care analysers in the key areas of Hematology and Diabetes
? Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.
EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.
Recommended Stories
- Five stocks we like better than EKF Diagnostics
- LightPath’s Defense Pivot Could Send Shares Higher
- Clearance to Climb: Why Allegiant Has Room to Fly
- 3 Defense Stocks Riding the High-Energy Laser Boom
- Analysts Are Punting Their Calls Into the Next Quarter After Adobe’s Mixed Earnings
Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
